1 888 2 DONATE
(1 888 236-6283)
Home
|
Shop
|
A-Z
|
Contact Us
|
Help
|
Français
CLINICS
DONORS
VOLUNTEERS
HOSPITALS
MEDIA ROOM
ABOUT US
CAREERS
Find a Clinic:
Search this site:
Home
>
What Should I Know?
>
Safety and Testing
Why Should I Donate?
•
Who Needs Blood?
•
It's Easy...Here's How!
Can I donate?
•
Basic Eligibility
•
Donor Questionnaire
•
Malaria policy
•
Donation Date Calculator
•
American Sign Language
What Can I Donate?
•
Types of Donations
•
Blood
•
Plasma & Platelets
•
Stem Cells
•
Financial Gifts
•
Blood for Research
How Can I Get Involved?
•
In My Community
•
Send an e-card
•
Public Involvement
•
Volunteers
•
Partners for Life
•
What's Your Type
•
Ready, Set...Give!
•
OneMatch
•
Young Blood For Life
•
National Blood Donor Week
What Should I Know?
•
Pandemic Preparedness
•
Safety and Testing
•
Research & Development
•
West Nile Virus (WNV)
•
Transfusion Related Acute Lung Injury (TRALI)
•
vCJD Travel Deferral
•
Blackboard
•
FAQs
Forms
•
Become a Volunteer
•
New Donor Form
•
Change Your Address
•
Join OneMatch
•
Become a Partner for Life Organization
•
Become a Partner for Life Member
•
Join Ready, Set... Give!
•
Donor Experience Survey
Hospitals
•
Customer Service
•
Circular of Information
•
Customer Letters
•
Plasma Protein Products
•
TransfusionMedicine.ca
•
Hospital Customer Forms
•
Resource Library
Chronology of events related to the MSM Policy
Year
Event
Sept. 2009
Trial between Canadian Blood Services and Kyle Freeman will begin in the Superior Court of Ontario in Ottawa
Sept. 2008
CBS forms national LGBTTQ (lesbian-gay-bisexual-transgendered-two-spirited or queer) working group, whose mandate is to act as a resource for CBS to help educate on the issues and sensitivities of the LGBTTQ community while helping to promote the research agenda.
March 2008
CBS launches joint research opportunity with the Canadian Institute for Health Research focused on three areas; donor deferral strategies and the risk of blood-borne diseases, policy development and social aspects of blood system risk, and emerging pathogens in specific populations
June 2007
CBS Board defers pursuing a deferral change while launching research agenda to close the gaps in information identified through the consultations.
2006
CBS conducted its own epidemiological study of 40,000 donors to evaluate the proportion of donors with deferrable risks. The study was repeated in 2008 with results published internally.
2006
American Red Cross, America's Blood Centres and the AABB recommend to the FDA changing deferral to 1 year for MSM - FDA chose to uphold the indefinite ban stating it was the best way to keep the nation's blood supply safe.
2006
McLaughlin Centre for Population Health Risk Assessment commissioned to conduct risk assessment of MSM donor deferral criteria - did not make recommendations, put forward views for discussion at CBS Board of Directors.
2001
CBS implements nucleic acid amplification testing (NAT) for HIV - greatly reducing the "window period" where the virus is undetectable by test, but not eliminating it.
2001
CBS/Hema-Quebec co-sponsored international consensus conference on optimizing the donor selection process - no recommendation to change criteria due to not enough evidence to implement a change in deferral criteria
1988
Year that the current MSM deferral was introduced in blood screening by the Canadian Red Cross via filling out a written questionnaire , a formal consent and confidential unit exclusion form
1985
The first year thousands of Canadians were infected with HIV via tainted blood
1983
The first year a pamphlet was introduced to donors outlining the risk factors for HIV, with the hope that donors would self-exclude.
1977
The year 1977 has been identified as the date when rapid spread of HIV began throughout first world countries such as the United States and Canada.
Printer-friendly
Safety and Testing
Safety and Testing
The Screening Process
Testing
False Positive Results
Nucleic Acid Testing
Leukoreduction
Blood Safety
Access to Information & Privacy Policies
|
Terms of Use
|
Copyright © 1998-2010 Canadian Blood Services. All rights reserved.